Protein Sciences "Dumbfounded" After Committee Votes Down FluBlok
This article was originally published in The Pink Sheet Daily
Executive Summary
Cell-based seasonal influenza vaccine needs both additional safety data in general and considerably more efficacy data in older patients, FDA advisory panel says.